Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.

Roudier, M P; Vesselle, H; True, L D; Higano, C S; Ott, S M; King, S H; Vessella, R L

Roudier, M P; Vesselle, H; True, L D; Higano, C S; Ott, S M; King, S H; Vessella, R L.

Affiliation

Roudier MP; Department of Urology, University of Washington, Seattle, Washington 98195, USA. mroudier@u.washington.edu

Clin Exp Metastasis ; 20(2): 171-80, 2003.

Article in En | MEDLINE | ID: mdl-12705638

Subject(s)

Antineoplastic Agents/therapeutic use; Bone Neoplasms/diagnostic imaging; Bone Neoplasms/secondary; Diphosphonates/therapeutic use; Prostatic Neoplasms/diagnostic imaging; Prostatic Neoplasms/pathology; Autopsy; Bone Neoplasms/drug therapy; Humans; Infusions, Intravenous; Male; Pamidronate; Predictive Value of Tests; Prostate-Specific Antigen/blood; Prostatic Neoplasms/drug therapy; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Bone Neoplasms / Diphosphonates / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Clin Exp Metastasis Journal subject: NEOPLASIAS Year: 2003 Document type: Article Affiliation country: United States Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links